25.01.2013 Views

Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

gle CD4 + T cells. Short-term culture of these cell suspensions in medium supplemented<br />

with human serum, <strong>and</strong> recombinant IL-2 <strong>and</strong> IL-7 leads to dramatic<br />

changes of the cellular composition. In about two-thirds of the cultured tumor cell<br />

suspensions there is marked lymphocyte proliferation that peaks between days 14<br />

<strong>and</strong> 21. Tumor cells rapidly decline because of both dilution <strong>and</strong> death in the culture<br />

dish. Proliferation of T lymphocytes does not preserve the original CD4/CD8 ratio.<br />

In fact, the dominant exp<strong>and</strong>ing population is CD3 + CD8 + . Monitoring of the expansion<br />

at the antigen-specific level is possible using tetramers. For Melan-A/MART-1<br />

tetramers, a 2000-fold expansion has been measured in the period of 21days. Since<br />

the size of the initial population could be determined with tetramers, it was possible<br />

to make a minimal estimate of 10±11 cell divisions during the culture period [71].<br />

Thus, two conclusions can be drawn from these observations. On one h<strong>and</strong>, the<br />

sheer numerical inferiority of Melan-A-reactive T cells accumulated in metastases<br />

may in itself account for the apparent lack of efficient antitumor activity. No additional<br />

defects may be invoked. Rapid tumor growth rates together with the lack of appropriate<br />

lymphocyte growth support signals in the tumor environment may suffice<br />

to explain the failure of T cells to exp<strong>and</strong> at the same or a faster pace than that of tumor<br />

cells. Eventually, the tumor would escape CTL control. On the other h<strong>and</strong>,<br />

Melan-A-specific T cells do not seem to bear major functional defects. They can proliferate<br />

vigorously in the presence of cytokines <strong>and</strong> residual tumor cells. The exp<strong>and</strong>ed<br />

population exhibits potent lytic activity against tumors <strong>and</strong> can release IFN-g<br />

specifically upon challenge with antigen-bearing tumors.<br />

Fig. 4.2 Dramatic changes in cellular composition<br />

of TILNs upon culture in the presence of<br />

cytokines. This cartoon summarizes the outcomes<br />

after in vitro culture of metastatic lymph<br />

node cell suspensions from melanoma patients<br />

in our laboratory. Culture in medium supplemented<br />

with fetal calf serum but devoid of cytokines<br />

favors the outgrowth of melanoma cell lines in<br />

close to 40% of cases. In contrast, culture in<br />

4.4 Monitoring the Spontaneous CTL Responses to Tumor Antigens<br />

medium supplemented with human serum, rIL-2<br />

<strong>and</strong> rIL-7 leads to dramatic expansions of T lymphocytes<br />

in about 60±70% of cases. The CD4/<br />

CD8 composition of these exp<strong>and</strong>ing cells also<br />

changes during expansion often resulting in<br />

large proportions of CD8 + T lymphocytes. Similar<br />

findings can be observed with TILs from dissociated<br />

metastatic melanoma tumors [105].<br />

Further details are explained in the text.<br />

47

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!